JPY 712.0
(0.42%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 96 Million | 533.44 Million | 543.51 Million | 224.21 Million | 308.58 Million |
Net Income | -194 Million | 424.61 Million | 444.33 Million | -247.83 Million | -54.41 Million |
Depreciation & Amortization | 264 Million | 164.16 Million | 148.27 Million | 175.04 Million | 169.86 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 12 Million | 14.55 Million | -109.59 Million | 97.29 Million | 219.54 Million |
Other non-cash items | 14 Million | 27.27 Million | 16.99 Million | 30.53 Million | -36.36 Million |
Investing Cash Flow | -504 Million | -468.13 Million | -35.02 Million | -33.05 Million | -959.22 Million |
Investments in PPE | -494 Million | -515.57 Million | -260.71 Million | -38.57 Million | -605.11 Million |
Acquisitions | - | 10.73 Million | 20.1 Million | - | -272.58 Million |
Investment purchases | -1.28 Million | -1.22 Million | -401 Thousand | -36.87 Million | -1.86 Million |
Sales/Maturities of investments | - | - | 43.41 Million | - | - |
Other Investing Activities | -10 Million | 37.93 Million | 162.57 Million | 42.39 Million | -99.22 Million |
Financing Cash Flow | -234 Million | -256.35 Million | -98.11 Million | 563.49 Million | 496.47 Million |
Debt repayment | -167 Million | -226.45 Million | -150.57 Million | -635.3 Million | -539.94 Million |
Dividends payments | -64 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 246 Thousand | 469 Thousand | 3.43 Million | 1.11 Million | 4.65 Million |
Other Financing Activities | -3 Million | -26.73 Million | -246.85 Million | -66.94 Million | -44.12 Million |
Accounts receivables | -35 Million | -3 Million | -41 Million | -32 Million | 44 Million |
Accounts payables | -24.23 Million | 59.71 Million | 33.29 Million | -6.14 Million | -96.05 Million |
Inventory | -18 Million | -12.3 Million | -1.21 Million | 590 Thousand | -2.63 Million |
Other working capital | 65 Million | -47 Million | -12 Million | 64 Million | 199 Million |
Cash at beginning of period | 2.12 Billion | 2.23 Billion | 1.8 Billion | 1.06 Billion | 1.21 Billion |
Cash at end of period | 1.5 Billion | 2.12 Billion | 2.23 Billion | 1.8 Billion | 1.06 Billion |
Capital Expenditure | -494 Million | -515.57 Million | -260.71 Million | -38.57 Million | -605.11 Million |
Effect of forex changes on cash | 19 Million | 77.86 Million | 20.57 Million | -11.84 Million | 4.51 Million |
Net cash flow / Change in cash | -622.72 Million | -113.16 Million | 430.95 Million | 742.8 Million | -149.65 Million |
Free Cash Flow | -398 Million | 17.87 Million | 282.79 Million | 185.64 Million | -296.53 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 90 Million | 4 Million | -194.16 Million | -109 Million | -30 Million | -29 Million |
Depreciation & Amortization | - | - | 264.65 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 37.37 Million | - | - | - |
Other non-cash items | -90 Million | -4 Million | 571.01 Million | 109 Million | 30 Million | 29 Million |
Investing Cash Flow | - | - | -504.56 Million | - | - | - |
Investments in PPE | - | - | -494.36 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -1.28 Million | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -8.91 Million | - | - | - |
Financing Cash Flow | - | - | -234.28 Million | - | - | - |
Debt repayment | - | - | -168.05 Million | - | - | - |
Dividends payments | - | - | -64 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 246 Thousand | - | - | - |
Other Financing Activities | - | - | -66.48 Million | - | - | - |
Accounts receivables | - | - | -10.06 Million | - | - | - |
Accounts payables | - | - | -24.23 Million | - | - | - |
Inventory | - | - | -18.63 Million | - | - | - |
Other working capital | - | - | 90.31 Million | - | - | - |
Cash at beginning of period | - | - | 2.12 Billion | - | - | - |
Cash at end of period | - | - | 1.5 Billion | - | - | - |
Capital Expenditure | - | - | -494.36 Million | - | - | - |
Effect of forex changes on cash | - | - | 19 Million | - | - | - |
Net cash flow / Change in cash | - | - | -622.72 Million | - | - | - |
Free Cash Flow | - | - | -397.72 Million | - | - | - |
BIOWKS
300078
FIN
GTK
9680
HLBBF